Please contact your conference representative to schedule a 1x1 meeting with Benitec management.

STOCKHOLM, SWEDEN / ACCESS Newswire / February 26, 2025 / Vicore Pharma Holding (STO:VICO) Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 ...

Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment ...

NEW YORK and BERLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage ...

Details of the company’s participation: Format: Fireside chat and 1x1 investor meetingsDate and Time: Fireside chat on Monday, March 3 at 11:50 A.M. ETWebcast link: Here An archived replay will ...

AUSTIN, Texas, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a leader in enterprise cloud solutions for ...

An archived replay will be available on the Investors section of the atai website under Events for up to 90 days. About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming ...

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. The Company was founded in response to the significant unmet need and lack of ...

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, ...